Markets:

Overview

News

Currencies

International

Treasuries

Avantis U.S. Equity ETF (NY:AVUS)

114.30 +0.65 (+0.57%)

Streaming Delayed Price Updated: 1:02 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avantis U.S. Equity ETF

< Previous 1 2 3 4 5 Next >

Regeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock Jumps ↗

July 02, 2025

While Lynozyfic was granted accelerated approval based on response rate in the LINKER-MM1 trial, continued approval may depend upon verification and description of clinical benefit in a confirmatory...

Via Stocktwits

Topics Death

Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results ↗

July 02, 2025

Organon said that the mid-stage study evaluating its OG-6219 in endometriosis-related pain did not demonstrate improvement in moderate-to-severe endometriosis-related overall pelvic pain compared to...

Via Stocktwits

Rivian Stock Slides After Sales Slump In Q2, Despite $1B Equity Boost From Volkswagen ↗

July 02, 2025

Rivian said production was limited during the quarter in preparation for model year 2026 vehicles, which are expected to launch later in July.

Via Stocktwits

Ford US Sales Surge 14% In Q2 Despite EV Slump: Pickup Trucks, SUVs Drive Demand ↗

July 01, 2025

The company’s truck sales jumped 11% in the three months through the end of June to 342,761 units, thanks to increased demand for the F-series, Ranger, and Maverick.

Via Stocktwits

Topics Electric Vehicles

Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial ↗

June 30, 2025

The data is key to receiving approvals for both the individual vaccine candidate and the company’s seasonal flu-COVID combination vaccine candidate.

Via Stocktwits

BioCryst To Sell European Business Of Its Hereditary Angioedema Drug To Pay Off Debt: Stock Rises While Retail Stays Bearish ↗

June 27, 2025

As per the terms of the agreement, Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to Orladeyo and the company will also be eligible to receive up...

Via Stocktwits

AT&T Gains FCC Approval to Replace Copper Lines With Wireless Tech ↗

December 24, 2024

AT&T (T) gets FCC approval to replace old copper home phone lines with wireless technology, expanding 5G network and fiber coverage for growth.

Via Benzinga

3 ETFs to Buy Now for High Returns and Low Risk ↗

May 18, 2023

These three ETFs to buy now try have delivered solid risk-adjusted returns to investors over the long haul.

Via InvestorPlace

ETF Battles: Which Value Equity ETF Is The Winner? ↗

January 13, 2023

An audience-requested quadruple header between 4 value equity ETFs from American Century, Charles Schwab, State Street Global Advisors, and Vanguard.

Via Talk Markets

ETF Battles: Which Broad Stock Market ETF Is Best? ↗

November 09, 2022

An audience-requested contest between broad stock market ETFs from American Century, State Street Global Advisors, and Vanguard.

Via Talk Markets

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.